Compared to rectal cancer, colon cancer more commonly exhibited higher activity of MAPK signaling pathways 33, elevated expression of HOX gene family 34, and constitutively active forms of BRAF 35, 36 and KRAS 37. This evidence concerns the gene KRAS and colonic neoplasm.